Osterweis Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-163
Closed -$46.3K 269
2025
Q4
$46.3K Hold
163
﹤0.01% 219
2025
Q3
$50.3K Hold
163
﹤0.01% 206
2025
Q2
$51.2K Buy
+163
New +$47K ﹤0.01% 211
2024
Q1
Sell
-35,881
Closed -$7.79M 200
2023
Q4
$7.79M Sell
35,881
-3,248
-8% -$557K 0.49% 57
2023
Q3
$6.24M Buy
39,129
+16,730
+75% +$3.75M 0.46% 61
2023
Q2
$6.46M Buy
22,399
+2,467
+12% +$749K 0.43% 66
2023
Q1
$6.36M Buy
19,932
+3,864
+24% +$1.15M 0.43% 67
2022
Q4
$4.73M Buy
16,068
+743
+5% +$205K 0.34% 78
2022
Q3
$3.52M Sell
15,325
-5,665
-27% -$1.42M 0.26% 88
2022
Q2
$4.58M Buy
20,990
+9,085
+76% +$2.07M 0.34% 75
2022
Q1
$3.17M Sell
11,905
-19,365
-62% -$4.75M 0.17% 101
2021
Q4
$8.32M Sell
31,270
-21,040
-40% -$6.1M 0.42% 76
2021
Q3
$14.9M Buy
52,310
+10,415
+25% +$2.97M 0.81% 43
2021
Q2
$11.5M Buy
41,895
+590
+1% +$160K 0.59% 58
2021
Q1
$10.8M Buy
41,305
+11,320
+38% +$3.03M 0.59% 54
2020
Q4
$7.67M Buy
29,985
+4,205
+16% +$1.04M 0.46% 64
2020
Q3
$6.1M Buy
25,780
+565
+2% +$119K 0.41% 61
2020
Q2
$4.9M Sell
25,215
-2,685
-10% -$513K 0.36% 71
2020
Q1
$4.62M Buy
27,900
+7,165
+35% +$1.31M 0.38% 60
2019
Q4
$3.55M Sell
20,735
-7,645
-27% -$1.27M 0.25% 72
2019
Q3
$4.68M Sell
28,380
-18,480
-39% -$2.6M 0.34% 62
2019
Q2
$5.59M Sell
46,860
-29,850
-39% -$3.06M 0.4% 57
2019
Q1
$7.29M Sell
76,710
-30,430
-28% -$2.61M 0.46% 57
2018
Q4
$8.5M Buy
107,140
+2,065
+2% +$175K 0.65% 49
2018
Q3
$11.1M Buy
105,075
+26,605
+34% +$2.49M 0.71% 44
2018
Q2
$6.72M Buy
+78,470
New +$7.04M 0.44% 53

Other funds holding PODD

Osterweis Capital Management's PODD Position: Q1 2026 in Review

Osterweis Capital Management sold out of Insulet (PODD) in Q1 2026, closing a stake of 163 shares — an estimated $46.3K sold.

Osterweis Capital Management first reported a position in PODD in Q2 2018 and held it in 26 quarters. The position peaked at $14.9M in Q3 2021. 785 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Osterweis Capital Management reported no remaining Insulet position as of Q1 2026 after selling out during the quarter.
  • Osterweis Capital Management sold 163 Insulet shares in Q1 2026, an estimated $46.3K.
  • Osterweis Capital Management first reported a position in Insulet in Q2 2018 and held it in 26 quarters.
  • Osterweis Capital Management's Insulet position peaked at $14.9M in Q3 2021.
  • 785 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Osterweis Capital Management's 13F filing for Q1 2026, filed 15 May 2026.